• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Around $5M Bet On This Communication Services Stock? Check Out These 4 Stocks Insiders Are Buying

    3/22/24 7:29:25 AM ET
    $CDLX
    $ESOA
    $PHUN
    $TRDA
    Computer Software: Programming Data Processing
    Technology
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials
    Get the next $CDLX alert in real time by email

    Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

    Cardlytics

    • The Trade: Cardlytics, Inc. (NASDAQ:CDLX) 10% owner Clifford Sosin acquired a total of 350,000 shares an average price of $14.16. To acquire these shares, it cost around $4.96 million.
    • What’s Happening: On March 18, Cardlytics entered an Equity Distribution Agreement pursuant to which the Company may issue and sell, from time to time up to $50 million.
    • What Cardlytics Does: Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications.

    Phunware

    • The Trade: Phunware, Inc. (NASDAQ:PHUN) CFO Troy Lee Reisner acquired a total of 2,000 shares at an average price of $8.76. To acquire these shares, it cost around $17,514.
    • What’s Happening: On March 12, Phunware reported worse-than-expected fourth-quarter EPS results.
    • What Phunware Does: Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences.

    Don’t forget to check out our premarket coverage here

    Energy Services of America

    • The Trade: Energy Services of America Corporation (NASDAQ:ESOA) Director Mark Prince bought a total of 14,000 shares at an average price of $8.17. To acquire these shares, it cost around $114,860.
    • What’s Happening: On March 6, Energy Services of America retained Three Part Advisors as investor relations counsel.
    • What Energy Services of America Does: Energy Services of America Corporation is engaged in providing contracting services for energy-related companies.

    Entrada Therapeutics

    • The Trade: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Director Peter S Kim bought a total of 2,732 shares at an average price of $12.81. The insider spent around $34,996 to buy those shares.
    • What’s Happening: On March 13, Entrada Therapeutics posted upbeat quarterly sales.
    • What Entrada Therapeutics Does: Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.

     

    Check This Out: Jim Cramer Likes Amazon More Than This E-Commerce Platform, Calls Chipotle 'The King'

    Get the next $CDLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CDLX
    $ESOA
    $PHUN
    $TRDA

    CompanyDatePrice TargetRatingAnalyst
    Entrada Therapeutics Inc.
    $TRDA
    2/11/2026$20.00Buy
    Guggenheim
    Entrada Therapeutics Inc.
    $TRDA
    1/28/2026$21.00Outperform
    Oppenheimer
    Energy Services of America Corporation
    $ESOA
    5/19/2025$21.00Buy
    Lake Street
    Entrada Therapeutics Inc.
    $TRDA
    12/6/2024$29.00Buy
    ROTH MKM
    Phunware Inc.
    $PHUN
    11/12/2024$9.00 → $6.00Buy → Neutral
    H.C. Wainwright
    Cardlytics Inc.
    $CDLX
    10/11/2024$4.00In-line
    Evercore ISI
    Cardlytics Inc.
    $CDLX
    8/16/2024$5.00Outperform → Market Perform
    Northland Capital
    Cardlytics Inc.
    $CDLX
    8/15/2024$4.00 → $3.50Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CDLX
    $ESOA
    $PHUN
    $TRDA
    SEC Filings

    View All

    SEC Form S-8 filed by Cardlytics Inc.

    S-8 - Cardlytics, Inc. (0001666071) (Filer)

    3/4/26 4:35:23 PM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology

    SEC Form 10-K filed by Cardlytics Inc.

    10-K - Cardlytics, Inc. (0001666071) (Filer)

    3/4/26 4:27:51 PM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology

    Cardlytics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Cardlytics, Inc. (0001666071) (Filer)

    3/4/26 4:05:19 PM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology

    $CDLX
    $ESOA
    $PHUN
    $TRDA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Entrada Therapeutics with a new price target

    Guggenheim initiated coverage of Entrada Therapeutics with a rating of Buy and set a new price target of $20.00

    2/11/26 7:51:55 AM ET
    $TRDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Oppenheimer initiated coverage on Entrada Therapeutics with a new price target

    Oppenheimer initiated coverage of Entrada Therapeutics with a rating of Outperform and set a new price target of $21.00

    1/28/26 7:58:46 AM ET
    $TRDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lake Street initiated coverage on Energy Services of America with a new price target

    Lake Street initiated coverage of Energy Services of America with a rating of Buy and set a new price target of $21.00

    5/19/25 8:52:31 AM ET
    $ESOA
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials

    $CDLX
    $ESOA
    $PHUN
    $TRDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Wentworth Kory James sold $97,892 worth of shares (7,988 units at $12.25), decreasing direct ownership by 5% to 137,987 units (SEC Form 4)

    4 - Entrada Therapeutics, Inc. (0001689375) (Issuer)

    3/6/26 4:36:45 PM ET
    $TRDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Doshi Dipal was granted 139,400 shares and covered exercise/tax liability with 29,050 shares, increasing direct ownership by 27% to 526,014 units (SEC Form 4)

    4 - Entrada Therapeutics, Inc. (0001689375) (Issuer)

    3/3/26 6:21:25 PM ET
    $TRDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Wentworth Kory James was granted 44,600 shares and covered exercise/tax liability with 8,651 shares, increasing direct ownership by 33% to 145,975 units (SEC Form 4)

    4 - Entrada Therapeutics, Inc. (0001689375) (Issuer)

    3/3/26 6:20:35 PM ET
    $TRDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CDLX
    $ESOA
    $PHUN
    $TRDA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cardlytics Announces Fourth Quarter and Full Year 2025 Financial Results

    Cardlytics, Inc. (NASDAQ:CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2025. "In 2025, we took several steps to reset our business and improve our financial health," said Amit Gupta, CEO of Cardlytics. "Going forward, we remain well positioned to execute our mandate and deliver for our partners and advertisers, even as we navigate a decrease in MQUs following the conclusion of our Bank of America campaigns in January. We are moving forward with sharper focus and discipline to control our own destiny by prioritizing our initiatives that build on our core fundamental strengths." "It has been reinvigorating to rejoin the Cardlytics team," s

    3/4/26 4:02:00 PM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology

    Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    BOSTON, March 02, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (NASDAQ:TRDA) today announced that the Company granted an aggregate of 12,990 restricted stock units ("RSUs") to two newly-hired non-executive employees under the Company's 2025 Inducement Equity Plan (the "Inducement Plan"), effective as of March 1, 2026. The inducement grants were previously approved by the Compensation Committee of the Company's Board of Directors, as a material inducement to the new employees' entry into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). One-fourth of the RSUs will vest on the one-year anniversary of the vesting commencement date, and 6.25% shall vest qua

    3/2/26 4:30:00 PM ET
    $TRDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Energy Services of America Corporation Announces Closing of Overallotment Option and Issuance of 261,000 Shares of Common Stock

    HUNTINGTON, W.Va., Feb. 24, 2026 /PRNewswire/ -- Energy Services of America Corporation (the "Company"), today announced that the underwriter for its recently completed public offering has exercised its overallotment option and completed the sale of an additional 261,000 shares of common stock at the public offering price of $11.50 per share. The proceeds to the Company in connection with the exercise of the option and the issuance of the additional shares, after deducting the underwriting discount and commissions but before deducting other expenses payable by the Company, are approximately $2.8 million.

    2/24/26 4:30:00 PM ET
    $ESOA
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials

    $CDLX
    $ESOA
    $PHUN
    $TRDA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Reynolds Douglas V covered exercise/tax liability with 3,251 shares and bought $75,615 worth of shares (9,100 units at $8.31), increasing direct ownership by 0.40% to 1,474,961 units (SEC Form 4)

    4 - Energy Services of America CORP (0001357971) (Issuer)

    12/23/25 9:28:44 AM ET
    $ESOA
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials

    Large owner Baker Bros. Advisors Lp bought $261,846 worth of shares (28,867 units at $9.07) (SEC Form 4)

    4 - Entrada Therapeutics, Inc. (0001689375) (Issuer)

    11/24/25 4:09:49 PM ET
    $TRDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Baker Bros. Advisors Lp bought $1,352,587 worth of shares (178,044 units at $7.60) (SEC Form 4)

    4 - Entrada Therapeutics, Inc. (0001689375) (Issuer)

    11/12/25 5:34:18 PM ET
    $TRDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CDLX
    $ESOA
    $PHUN
    $TRDA
    Leadership Updates

    Live Leadership Updates

    View All

    Cardlytics Appoints Company Alumnus David Evans as Chief Financial Officer

    Cardlytics Inc. (NASDAQ:CDLX) today announced the appointment of David Evans as its new Chief Financial Officer, effective January 12, 2026. Evans is returning to Cardlytics, having previously held several executive roles including Chief Financial Officer and Chief Administrative Officer. As the returning Chief Financial Officer, Evans will oversee Cardlytics' finance, accounting, and investor relations functions as the company continues to execute against its longer-term growth vision. Evans rejoins Cardlytics after his initial tenure from 2014 to 2020, during which he helped guide the company through its earlier years of growth and a successful IPO in 2018. Evans is a seasoned executive

    12/18/25 8:10:00 AM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology

    Phunware Announces Appointment of Elliot Han as Chairperson of the Board of Directors

    Experienced Corporate Finance and Technology/Digital-Asset Leader to Guide Board Strategy and Growth Initiatives AUSTIN, Texas, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. ("Phunware" or the "Company") (NASDAQ:PHUN), the enterprise cloud platform for mobile that provides products, solutions, data, and services for brands to engage, manage and monetize global audiences, today announced that Elliot Han was appointed Chairperson of the Company's Board of Directors and Chairperson of the Board's Audit Committee, each effective October 2025. Mr. Han has served as a Class II non-employee Director on the Company's Board since January 2024 and will continue to chair the Board's Compensation

    12/2/25 8:31:00 AM ET
    $PHUN
    EDP Services
    Technology

    Phunware Announces Appointment of Jeremy Krol to Board of Directors

    Appointment Fills Vacant Position on Board of Directors AUSTIN, Texas, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. ("Phunware" or the "Company") (NASDAQ:PHUN), the enterprise cloud platform for mobile that provides products, solutions, data, and services for brands to engage, manage and monetize global audiences, today announced the appointment of Jeremy Krol to its Board of Directors, effective immediately. Mr. Krol, who served as Phunware's COO before accepting a position as Interim Chief Executive Officer in July 2025, will continue in that leadership position in addition to joining the Board. Krol began his tenure at Phunware in June 2024 and brings more than 20 years of experie

    10/22/25 8:05:00 AM ET
    $PHUN
    EDP Services
    Technology

    $CDLX
    $ESOA
    $PHUN
    $TRDA
    Financials

    Live finance-specific insights

    View All

    Cardlytics Announces Fourth Quarter and Full Year 2025 Financial Results

    Cardlytics, Inc. (NASDAQ:CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2025. "In 2025, we took several steps to reset our business and improve our financial health," said Amit Gupta, CEO of Cardlytics. "Going forward, we remain well positioned to execute our mandate and deliver for our partners and advertisers, even as we navigate a decrease in MQUs following the conclusion of our Bank of America campaigns in January. We are moving forward with sharper focus and discipline to control our own destiny by prioritizing our initiatives that build on our core fundamental strengths." "It has been reinvigorating to rejoin the Cardlytics team," s

    3/4/26 4:02:00 PM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology

    Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2025 Earnings Release

    Cardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the fourth quarter and full year ending December 31, 2025 will be released on March 4, 2026, after market close. Conference Call Details: When: March 4, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial +1 800-549-8228 and use Conference ID: 74668. About Cardlytics Cardlytics (NASDAQ:CDLX) is a commerce media platform, powered by our publishers' firs

    2/19/26 4:05:00 PM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology

    Energy Services of America Reports Fourth Quarter and Full Year Fiscal 2025 Results

    Records 16.8% Annual Revenue Increase and Highest Quarterly Revenue in Company History   HUNTINGTON, W.Va., Dec. 9, 2025 /PRNewswire/ -- Energy Services of America Corporation (the "Company" or "Energy Services") (NASDAQ:ESOA), today announced its results for its fourth quarter and fiscal year ended September 30, 2025. Fourth Quarter Highlights (1) Revenue of $130.1 million versus $104.7 millionGross profit of $16.5 million versus $17.6 millionNet income of $4.2 million, or $0.25 per diluted share, compared to $6.7 million, or $0.40 per diluted share.Adjusted EBITDA of $11.3 m

    12/9/25 6:22:00 PM ET
    $ESOA
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials

    $CDLX
    $ESOA
    $PHUN
    $TRDA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Entrada Therapeutics Inc.

    SC 13G/A - Entrada Therapeutics, Inc. (0001689375) (Subject)

    11/14/24 1:22:40 PM ET
    $TRDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Energy Services of America Corporation

    SC 13G/A - Energy Services of America CORP (0001357971) (Subject)

    8/23/24 10:18:12 AM ET
    $ESOA
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials

    Amendment: SEC Form SC 13D/A filed by Cardlytics Inc.

    SC 13D/A - Cardlytics, Inc. (0001666071) (Subject)

    7/2/24 7:05:14 PM ET
    $CDLX
    Computer Software: Programming Data Processing
    Technology